Cargando…
Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma
Multiple myeloma (MM), the second most common hematologic cancer, is caused by accumulation of aberrant plasma cells in the bone marrow. Its molecular causes are not fully understood and its great heterogeneity among patients complicates therapeutic decision-making. In the past decades, development...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Open Exploration
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400753/ https://www.ncbi.nlm.nih.gov/pubmed/36046090 http://dx.doi.org/10.37349/etat.2021.00034 |